Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis - PubMed (original) (raw)
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis
S Banai et al. Cardiovasc Res. 1994 Aug.
Abstract
Objective: The process of coronary collateral development is poorly understood. It is assumed that particular angiogenic factors are upregulated during episodes of myocardial ischaemia and act as a trigger for neovascularisation. However, the identity of these factors is unknown. The angiogenic factor vascular endothelial growth factor (VEGF) has been shown to be hypoxia inducible, so this factor may mediate ischaemia induced angiogenesis in the heart. The aim of this study was to examine hypoxia inducibility of VEGF in cultured myocardial cells as well as in normally perfused and ischaemic porcine myocardium.
Methods: (1) In vitro experiment: cultured rat myocardial cells were subjected to hypoxia, and steady state levels of VEGF mRNA were measured after 2 and 4 h of hypoxia. (2) In vivo experiment: myocardial ischaemia in pigs hearts was induced by repeated 2-10 min left anterior descending coronary artery occlusions, separated by 20 min of reperfusion. Hearts were retrieved after 6 h of intermittent ischaemia. Total RNA was extracted from normal and ischaemic zones of the heart and processed for RNA blot hybridisation analysis.
Results: In vitro experiment: as soon as 2-4 h after exposure of cultures to hypoxia, VEGF mRNA levels were significantly raised (6-10-fold). In vivo experiment: VEGF expression was significantly augmented in the ischaemic territory of the myocardium (three- to fivefold induction). Furthermore, polymerase chain reaction amplification of the reverse transcribed mRNA showed increased production of multiple forms of differentially spliced VEGF mRNA in the ischaemic myocardium.
Conclusions: VEGF production in the myocardium is significantly upregulated by hypoxia in vitro and by ischaemia in vivo. These results suggest that VEGF is a likely mediator in the natural process of ischaemia induced myocardial neovascularisation.
Similar articles
- Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart.
Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. Hashimoto E, et al. Am J Physiol. 1994 Nov;267(5 Pt 2):H1948-54. doi: 10.1152/ajpheart.1994.267.5.H1948. Am J Physiol. 1994. PMID: 7977826 - Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium.
Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, Hatanaka K, Kobayashi M, Ueyama T, Hashimoto T, Dohi K. Kawata H, et al. Circ Res. 2001 Apr 13;88(7):696-704. doi: 10.1161/hh0701.088842. Circ Res. 2001. PMID: 11304492 - Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes.
Balasubramanian S, Ramakrishnan S, Charboneau R, Wang J, Barke RA, Roy S. Balasubramanian S, et al. J Mol Cell Cardiol. 2001 Dec;33(12):2179-87. doi: 10.1006/jmcc.2001.1480. J Mol Cell Cardiol. 2001. PMID: 11735263 - Myocardial VEGF expression after cardiopulmonary bypass and cardioplegia.
Tofukuji M, Metais C, Li J, Franklin A, Simons M, Sellke FW. Tofukuji M, et al. Circulation. 1998 Nov 10;98(19 Suppl):II242-6; discussion II247-8. Circulation. 1998. PMID: 9852909 - Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart.
Maulik N, Das DK. Maulik N, et al. J Cell Mol Med. 2002 Jan-Mar;6(1):13-24. doi: 10.1111/j.1582-4934.2002.tb00308.x. J Cell Mol Med. 2002. PMID: 12003666 Free PMC article. Review.
Cited by
- Improvement of myocardial perfusion in coronary patients after intermittent hypobaric hypoxia.
del Pilar Valle M, García-Godos F, Woolcott OO, Marticorena JM, Rodríguez V, Gutiérrez I, Fernández-Dávila L, Contreras A, Valdivia L, Robles J, Marticorena EA. del Pilar Valle M, et al. J Nucl Cardiol. 2006 Jan-Feb;13(1):69-74. doi: 10.1016/j.nuclcard.2005.11.008. J Nucl Cardiol. 2006. PMID: 16464719 Clinical Trial. - Serum vascular endothelial growth factor levels in various liver diseases.
Akiyoshi F, Sata M, Suzuki H, Uchimura Y, Mitsuyama K, Matsuo K, Tanikawa K. Akiyoshi F, et al. Dig Dis Sci. 1998 Jan;43(1):41-5. doi: 10.1023/a:1018863718430. Dig Dis Sci. 1998. PMID: 9508533 - HIF-1 alpha is required for solid tumor formation and embryonic vascularization.
Ryan HE, Lo J, Johnson RS. Ryan HE, et al. EMBO J. 1998 Jun 1;17(11):3005-15. doi: 10.1093/emboj/17.11.3005. EMBO J. 1998. PMID: 9606183 Free PMC article. - Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury.
Mohan M, Mannan A, Singh TG. Mohan M, et al. Pharmacol Rep. 2023 Aug;75(4):838-860. doi: 10.1007/s43440-023-00505-0. Epub 2023 Jun 22. Pharmacol Rep. 2023. PMID: 37347388 Review. - Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF.
Roguin A, Avivi A, Nitecki S, Rubinstein I, Levy NS, Abassi ZA, Resnick MB, Lache O, Melamed-Frank M, Joel A, Hoffman A, Nevo E, Levy AP. Roguin A, et al. Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4644-8. doi: 10.1073/pnas.0330833100. Epub 2003 Apr 2. Proc Natl Acad Sci U S A. 2003. PMID: 12672967 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources